Overexpression of ZNRF3 inhibited cell growth and attenuated the tumor-promoting effects of miR-146a via inhibition of GSK-3β/β-catenin signaling, indicating that miR-146a may function as a tumor suppressor and represent a potential biomarker for OS patients. This evidence concerns the gene ZNRF3 and neoplasm.